Promising future therapies for asthma
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference41 articles.
1. The global burden of asthma;Braman;Chest,2006
2. National asthma education and prevention program Expert Panel Report 3: guidelines for the diagnosis and management of asthma;NHLBI,2007
3. Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone;Bateman;Thorax,2014
4. Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52weeks in patients >=12years old with asthma: a randomised trial;Busse;Thorax,2013
5. Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial;Woodcock;Chest,2013
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Amino acid-based stable adalimumab formulation in spray freeze-dried microparticles for pulmonary delivery;Journal of Drug Delivery Science and Technology;2019-12
2. Chinese expert consensus on diagnosis and management of severe asthma;Journal of Thoracic Disease;2018-12
3. Human lung tissue provides highly relevant data about efficacy of new anti-asthmatic drugs;PLOS ONE;2018-11-30
4. Modulation of the TRPV4 ion channel as a therapeutic target for disease;Pharmacology & Therapeutics;2017-09
5. p300 and C/EBPβ-regulated IKKβ expression are involved in thrombin-induced IL-8/CXCL8 expression in human lung epithelial cells;Pharmacological Research;2017-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3